{"id":63631,"date":"2026-04-21T17:52:58","date_gmt":"2026-04-21T09:52:58","guid":{"rendered":"https:\/\/flcube.com\/?p=63631"},"modified":"2026-04-21T17:52:59","modified_gmt":"2026-04-21T09:52:59","slug":"china-tightens-control-over-pregabalin-and-dextromethorphan-guaifenesin-preparations-amid-abuse-concerns-nmpa-police-and-narcotics-agency-issue-joint-enforcement-directive","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=63631","title":{"rendered":"China Tightens Control Over Pregabalin and Dextromethorphan-Guaifenesin Preparations Amid Abuse Concerns; NMPA, Police, and Narcotics Agency Issue Joint Enforcement Directive"},"content":{"rendered":"\n<p>China\u2019s <strong>National Medical Products Administration (NMPA)<\/strong>, in coordination with the <strong>Ministry of Public Security<\/strong> and the <strong>Office of the National Narcotics Control Commission<\/strong>, has issued a <strong>joint regulatory notice<\/strong> imposing stringent new controls on <strong>oral single-ingredient pregabalin preparations<\/strong> and <strong>guaifenesin-containing cough syrups<\/strong> (defined as formulations containing only <strong>dextromethorphan and guaifenesin or guaifenesin glyceryl ether<\/strong>). The move reflects escalating concerns over non-medical use and diversion of these substances.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-key-regulatory-measures\">Key Regulatory Measures<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Requirement<\/th><th>Scope<\/th><\/tr><\/thead><tbody><tr><td><strong>API Quota Cap<\/strong><\/td><td>Annual dextromethorphan API allocation for guaifenesin-combo production <strong>capped at prior-year levels<\/strong><\/td><\/tr><tr><td><strong>Purchaser Verification<\/strong><\/td><td>Mandatory validation of buyer credentials, procurement staff ID, and specimen seals\/signatures<\/td><\/tr><tr><td><strong>Sales Monitoring<\/strong><\/td><td>Distributors must conduct <strong>dynamic monitoring<\/strong> and <strong>regular audits<\/strong> of sales patterns<\/td><\/tr><tr><td><strong>Abnormal Purchase Review<\/strong><\/td><td>Triggered if volumes exceed normal business scale; requires evaluation of buyer\u2019s safe handling protocols<\/td><\/tr><tr><td><strong>Transaction Rules<\/strong><\/td><td><strong>Cash transactions prohibited<\/strong>; all payments must be traceable<\/td><\/tr><tr><td><strong>Online Sales Ban<\/strong><\/td><td><strong>All online retail\u2014direct or disguised\u2014is forbidden<\/strong><\/td><\/tr><tr><td><strong>Pharmacy Protocols<\/strong><\/td><td>Dedicated counters, trained staff, and <strong>separate physical registers<\/strong> required at point of sale<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-registration-requirements-for-retail-pharmacies\">Registration Requirements for Retail Pharmacies<\/h2>\n\n\n\n<p>Each transaction must record:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Drug name and specification<\/li>\n\n\n\n<li>Sales quantity<\/li>\n\n\n\n<li>Manufacturer and batch number<\/li>\n\n\n\n<li>Purchase date<\/li>\n\n\n\n<li>Purchaser\u2019s full name and <strong>national ID number<\/strong><\/li>\n<\/ul>\n\n\n\n<p>This level of documentation mirrors controls applied to <strong>Schedule II psychotropic substances<\/strong> under Chinese law, signaling a de facto reclassification in practice\u2014even if not formally relabeled.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-background-amp-rationale\">Background &amp; Rationale<\/h2>\n\n\n\n<p>While <strong>pregabalin<\/strong> is approved for neuropathic pain and epilepsy, and <strong>dextromethorphan-guaifenesin<\/strong> combinations are common OTC cough remedies, both have been increasingly abused for psychoactive effects\u2014particularly among adolescents. Recent seizures and social media-fueled misuse trends prompted inter-agency intervention.<\/p>\n\n\n\n<p>The policy aligns with China\u2019s broader <strong>\u201czero tolerance\u201d narcotics strategy<\/strong>, which has previously led to strict controls on tramadol, codeine, and ephedrine-containing products.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-industry-impact\">Industry Impact<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Manufacturers<\/strong>: Face reduced API quotas and heightened compliance burdens; innovation in abuse-deterrent formulations may accelerate<\/li>\n\n\n\n<li><strong>Distributors<\/strong>: Must implement real-time analytics to flag anomalous orders<\/li>\n\n\n\n<li><strong>Retailers<\/strong>: Increased operational costs due to dedicated staffing and manual logging<\/li>\n\n\n\n<li><strong>Market Contraction<\/strong>: Legal sales volume expected to decline 20\u201330% in 2026\u20132027 as access tightens<\/li>\n<\/ul>\n\n\n\n<p>Multinational pharma firms with OTC portfolios in China\u2014including <strong>GSK<\/strong>, <strong>Pfizer<\/strong>, and <strong>Sanofi<\/strong>\u2014are assessing supply chain adjustments. Domestic players like <strong>Jiangsu Hengrui<\/strong> and <strong>Harbin Pharmaceutical<\/strong> may pivot to alternative cough\/cold formulations.<\/p>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief summarizes regulatory actions by Chinese authorities. Compliance timelines, enforcement rigor, and market responses remain subject to local implementation and monitoring.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China\u2019s National Medical Products Administration (NMPA), in coordination with the Ministry of Public Security and&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[4],"tags":[],"class_list":["post-63631","post","type-post","status-publish","format-standard","hentry","category-policy-regulatory"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>China Tightens Control Over Pregabalin and Dextromethorphan-Guaifenesin Preparations Amid Abuse Concerns; NMPA, Police, and Narcotics Agency Issue Joint Enforcement Directive - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China\u2019s National Medical Products Administration (NMPA), in coordination with the Ministry of Public Security and the Office of the National Narcotics Control Commission, has issued a joint regulatory notice imposing stringent new controls on oral single-ingredient pregabalin preparations and guaifenesin-containing cough syrups (defined as formulations containing only dextromethorphan and guaifenesin or guaifenesin glyceryl ether). The move reflects escalating concerns over non-medical use and diversion of these substances.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=63631\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"China Tightens Control Over Pregabalin and Dextromethorphan-Guaifenesin Preparations Amid Abuse Concerns; NMPA, Police, and Narcotics Agency Issue Joint Enforcement Directive\" \/>\n<meta property=\"og:description\" content=\"China\u2019s National Medical Products Administration (NMPA), in coordination with the Ministry of Public Security and the Office of the National Narcotics Control Commission, has issued a joint regulatory notice imposing stringent new controls on oral single-ingredient pregabalin preparations and guaifenesin-containing cough syrups (defined as formulations containing only dextromethorphan and guaifenesin or guaifenesin glyceryl ether). The move reflects escalating concerns over non-medical use and diversion of these substances.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=63631\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-21T09:52:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-21T09:52:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63631#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63631\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"China Tightens Control Over Pregabalin and Dextromethorphan-Guaifenesin Preparations Amid Abuse Concerns; NMPA, Police, and Narcotics Agency Issue Joint Enforcement Directive\",\"datePublished\":\"2026-04-21T09:52:58+00:00\",\"dateModified\":\"2026-04-21T09:52:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63631\"},\"wordCount\":420,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"articleSection\":[\"Policy \\\/ Regulatory\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=63631#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63631\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=63631\",\"name\":\"China Tightens Control Over Pregabalin and Dextromethorphan-Guaifenesin Preparations Amid Abuse Concerns; NMPA, Police, and Narcotics Agency Issue Joint Enforcement Directive - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-04-21T09:52:58+00:00\",\"dateModified\":\"2026-04-21T09:52:59+00:00\",\"description\":\"China\u2019s National Medical Products Administration (NMPA), in coordination with the Ministry of Public Security and the Office of the National Narcotics Control Commission, has issued a joint regulatory notice imposing stringent new controls on oral single-ingredient pregabalin preparations and guaifenesin-containing cough syrups (defined as formulations containing only dextromethorphan and guaifenesin or guaifenesin glyceryl ether). The move reflects escalating concerns over non-medical use and diversion of these substances.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63631#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=63631\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63631#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"China Tightens Control Over Pregabalin and Dextromethorphan-Guaifenesin Preparations Amid Abuse Concerns; NMPA, Police, and Narcotics Agency Issue Joint Enforcement Directive\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"China Tightens Control Over Pregabalin and Dextromethorphan-Guaifenesin Preparations Amid Abuse Concerns; NMPA, Police, and Narcotics Agency Issue Joint Enforcement Directive - Insight, China&#039;s Pharmaceutical Industry","description":"China\u2019s National Medical Products Administration (NMPA), in coordination with the Ministry of Public Security and the Office of the National Narcotics Control Commission, has issued a joint regulatory notice imposing stringent new controls on oral single-ingredient pregabalin preparations and guaifenesin-containing cough syrups (defined as formulations containing only dextromethorphan and guaifenesin or guaifenesin glyceryl ether). The move reflects escalating concerns over non-medical use and diversion of these substances.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=63631","og_locale":"en_US","og_type":"article","og_title":"China Tightens Control Over Pregabalin and Dextromethorphan-Guaifenesin Preparations Amid Abuse Concerns; NMPA, Police, and Narcotics Agency Issue Joint Enforcement Directive","og_description":"China\u2019s National Medical Products Administration (NMPA), in coordination with the Ministry of Public Security and the Office of the National Narcotics Control Commission, has issued a joint regulatory notice imposing stringent new controls on oral single-ingredient pregabalin preparations and guaifenesin-containing cough syrups (defined as formulations containing only dextromethorphan and guaifenesin or guaifenesin glyceryl ether). The move reflects escalating concerns over non-medical use and diversion of these substances.","og_url":"https:\/\/flcube.com\/?p=63631","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-04-21T09:52:58+00:00","article_modified_time":"2026-04-21T09:52:59+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=63631#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=63631"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"China Tightens Control Over Pregabalin and Dextromethorphan-Guaifenesin Preparations Amid Abuse Concerns; NMPA, Police, and Narcotics Agency Issue Joint Enforcement Directive","datePublished":"2026-04-21T09:52:58+00:00","dateModified":"2026-04-21T09:52:59+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=63631"},"wordCount":420,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"articleSection":["Policy \/ Regulatory"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=63631#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=63631","url":"https:\/\/flcube.com\/?p=63631","name":"China Tightens Control Over Pregabalin and Dextromethorphan-Guaifenesin Preparations Amid Abuse Concerns; NMPA, Police, and Narcotics Agency Issue Joint Enforcement Directive - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-04-21T09:52:58+00:00","dateModified":"2026-04-21T09:52:59+00:00","description":"China\u2019s National Medical Products Administration (NMPA), in coordination with the Ministry of Public Security and the Office of the National Narcotics Control Commission, has issued a joint regulatory notice imposing stringent new controls on oral single-ingredient pregabalin preparations and guaifenesin-containing cough syrups (defined as formulations containing only dextromethorphan and guaifenesin or guaifenesin glyceryl ether). The move reflects escalating concerns over non-medical use and diversion of these substances.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=63631#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=63631"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=63631#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"China Tightens Control Over Pregabalin and Dextromethorphan-Guaifenesin Preparations Amid Abuse Concerns; NMPA, Police, and Narcotics Agency Issue Joint Enforcement Directive"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/63631","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=63631"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/63631\/revisions"}],"predecessor-version":[{"id":63633,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/63631\/revisions\/63633"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=63631"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=63631"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=63631"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}